Adicet Bio Inc. (ACET)
0.87
-0.03 (-3.20%)
At close: Mar 03, 2025, 11:29 AM
Adicet Bio Income Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
Revenue | n/a | 24.99M | 9.73M | 17.9M | 995K | 8.18M | 558.52M | 546.95M | 510.18M | 499.69M | 499.69M | 444.39M | 412.43M | 346.63M | 322.65M | 359.59M |
Cost of Revenue | 6.1M | 5.01M | n/a | n/a | 125K | 80K | 5K | 411.52M | 395.48M | 401.42M | 401.42M | 362.36M | 346.59M | 292.48M | 267.03M | 292.29M |
Gross Profit | -6.1M | 19.98M | 9.73M | 17.9M | 870K | 8.1M | 558.52M | 135.43M | 114.7M | 98.27M | 98.27M | 82.03M | 65.84M | 54.16M | 55.62M | 67.31M |
Operating Income | -152.04M | -72.55M | -61.43M | -39.19M | -31.39M | -14.96M | -18.88M | -1K | 44.27M | 34.42M | 34.42M | 25.37M | 16.55M | 9.44M | 11.89M | 21.38M |
Interest Income | 9.95M | 3.76M | 91K | 785K | 938K | 543K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -142.66M | -69.79M | -62.12M | -39.49M | -28.12M | -9.89M | -33.78M | -1K | 44.67M | 34.55M | 34.55M | 24.74M | 16.96M | 10.2M | 12.73M | 22.19M |
Net Income | -142.66M | -67.03M | -62M | -36.68M | -28.14M | -9.3M | -33.78M | -1K | 29M | 22.33M | 22.33M | 16.98M | 8.97M | 6.58M | 8.63M | 13.47M |
Selling & General & Admin | 26.53M | 26.3M | 22.22M | 22.76M | 8.69M | 8.43M | 2.04M | 1K | 65.21M | 61.02M | 63.85M | 56.67M | 49.29M | 44.72M | 43.57M | 45.42M |
Research & Development | 106.04M | 71.25M | 48.94M | 34.33M | 23.69M | 14.72M | 16.84M | 5.94M | 5.22M | 2.83M | n/a | n/a | n/a | n/a | 153K | 506K |
Other Expenses | 19.46M | -919K | -606K | -953K | 2.33M | 4.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 152.04M | 97.54M | 71.16M | 57.09M | 32.38M | 23.14M | 18.88M | 1K | 70.43M | 63.85M | 63.85M | 56.67M | 49.29M | 44.72M | 43.73M | 45.93M |
Interest Expense | n/a | 80K | 176K | 134K | n/a | n/a | 7M | 3.95M | 2.1M | 2.12M | 2.12M | 2.63M | 1.57M | 230K | 98K | 145K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -74.78M | -73.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 152.04M | 97.54M | 71.16M | 57.09M | 32.38M | 23.14M | 18.88M | 1K | 465.91M | 465.27M | 465.27M | 419.02M | 395.88M | 337.19M | 310.75M | 338.21M |
Income Tax | n/a | -2.76M | -125K | -2.81M | 19K | -589K | 19.09M | 20.38M | 15.67M | 12.22M | 12.22M | 7.76M | 7.99M | 3.62M | 4.1M | 8.72M |
Shares Outstanding (Basic) | 43.04M | 41.08M | 30.95M | 7.32M | 18.56M | 29.8M | 26.77M | 28.05M | 24.5M | 23.67M | 23.67M | 23.26M | 22.67M | 21.86M | 21.43M | 21.3M |
Shares Outstanding (Diluted) | 43.04M | 41.08M | 30.95M | 7.32M | 18.56M | 29.8M | 26.97M | 28.05M | 24.99M | 24.02M | 24.02M | 23.46M | 22.84M | 22.07M | 21.86M | 21.7M |
EPS (Basic) | -3.31 | -1.63 | -2 | -5.01 | -1.52 | -0.31 | -1.26 | n/a | 1.18 | 0.94 | 0.94 | 0.73 | 0.40 | 0.30 | 0.40 | 0.63 |
EPS (Diluted) | -3.31 | -1.63 | -2 | -5.01 | -1.52 | -0.31 | -1.25 | n/a | 1.16 | 0.93 | 0.93 | 0.72 | 0.39 | 0.30 | 0.39 | 0.62 |
EBITDA | -136.53M | -64.7M | -60.41M | -37.41M | -26.88M | -13.74M | -33.77M | -1K | 54.87M | 43.62M | 43.62M | 34.31M | 24.03M | 13.23M | 14.7M | 24.71M |
Depreciation & Amortization | 6.1M | 5.01M | 4.07M | 1.95M | 1.24M | 80K | 5K | 11.85M | 8.09M | 6.94M | 6.94M | 6.94M | 5.5M | 2.8M | 1.87M | 2.38M |